MedPath

Effectivity of Neurofeedback in youth with AD(H)D-problems and comorbid disorders: a randomized controlled trial.

Recruiting
Conditions
eurofeedbackADHDEEG
Registration Number
NL-OMON22925
Lead Sponsor
Zon MW
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
150
Inclusion Criteria

* Male * Between 12 and 24 years old *A positive screen on the screeningslist ADHD of Kooij (clinical: more than six points on one of the scales or subclinical: four or more points on one of the scales) or a DSM IV diagnosis ADHD *Dutch as native language *Diagnosed with a comorbid disorder.

Exclusion Criteria

*A total IQ-score < 80 points on the WAIS or WISC intelligence scales *An instable EEG-pattern (epilepsy) *Having a medical condition that account for attentional problems or hyperactivity (organic brain damage), presentation of a psychotic disorder or schizophrenia.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The effectivity of neurofeedback is investigated with different study parameters. We expect that the brain after neurofeedback will be better capable to proces information than before the neurofeedback; this will be indicated using Event Related Potentials which are determined during the QEEG. Also we expect that the sustained and selective attention and concentration will increase and the executive functions improve. To indicates these changes (neuro)psychological tests will be assessed. Whenever the fundamental problems of AD(H)D-problems are effectively treated we expect that the related behavior problems decrease. Therefore behavioral changes will be investigated using behavioral questionnaires and an interview.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath